XTX Topco
TLX icon

XTX Topco’s Telix Pharmaceuticals TLX Stock Holding History

XTX Topco’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$793K Buy
68,776
+42,769
+164% +$435K 0.01% 2013
2026
Q1 		$249K Buy
26,007
+14,187
+120% +$108K ﹤0.01% 2653
2025
Q4 		$88.5K Buy
+11,820
New +$114K ﹤0.01% 2666

Other funds holding TLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
PIC
Portland Investment Counsel Burlington, Ontario, Canada $358M AUM 26.37% 1-Year Est. Return
Private Advisor Group
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Integrated Wealth Concepts
Integrated Wealth Concepts Waltham, Massachusetts $15.3B AUM 25.33% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

XTX Topco's TLX Position: Q2 2026 in Review

XTX Topco increased its Telix Pharmaceuticals (TLX) stake by 164% in Q2 2026, buying an estimated $435K and bringing the position to 68,776 shares worth $793K. The position accounts for 0.01% of the portfolio, ranked #2013.

XTX Topco first reported a position in TLX in Q4 2025 and has held it in 3 quarters since. 61 funds tracked by Wall St. Rank hold TLX as of Q2 2026.

  • XTX Topco held 68,776 shares of Telix Pharmaceuticals worth $793K as of Q2 2026.
  • XTX Topco bought 42,769 Telix Pharmaceuticals shares in Q2 2026, an estimated $435K.
  • Telix Pharmaceuticals made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2013 holding.
  • XTX Topco first reported a position in Telix Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 61 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.